Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04236726
NCT04236726
Recruiting
Not Applicable

Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure

Guy's and St Thomas' NHS Foundation Trust1 site in 1 country200 target enrollmentDecember 19, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Obstructive Pulmonary DiseaseRespiratory FailureNeuromuscular DiseasesVentilatory Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Enrollment
200
Locations
1
Primary Endpoint
HRQoL score
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

To determine the quality of life of patients living with chronic respiratory failure and the impact interventions have on it.

Detailed Description

To determine the quality of life of patients living with chronic respiratory failure and the impact interventions have on it.

Registry
clinicaltrials.gov
Start Date
December 19, 2019
End Date
May 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Diagnosed with chronic respiratory failure receiving any of:
  • •Non-invasive ventilation
  • •Prolonged mechanical ventilation
  • •Mechanical insufflation-exsufflation therapy

Exclusion Criteria

  • •Aged \<18
  • •Significant physical or psychiatric co-morbidity that would prevent compliance with trial protocol

Outcomes

Primary Outcomes

HRQoL score

Time Frame: Day 0: At the first outpatient clinical consultation with the clinical team

Outcome of various HRQoL assessment tools.

Secondary Outcomes

  • Change in HRQoL score(6 months following first assessment for Outcome 1)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025Radiation ToxicityChemotherapeutic ToxicityChemotherapy-induced Peripheral NeuropathyDelayed Wound HealingChronic PainRefractory Pain
NCT05417737Bernardino Clavo, MD, PhD105
Completed
Not Applicable
Cardiorespiratory Assessment and Quality of Life After Surgical Correction of Congenital Wall MalformationsFunnel Chest
NCT03770390University Hospital, Montpellier43
Completed
Phase 4
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive
NCT03478683GlaxoSmithKline729
Completed
Phase 4
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive
NCT03478696GlaxoSmithKline732
Completed
Not Applicable
Quality of Life and Long-term Outcomes After Hospitalization for COVID-19Quality of LifeLong-term OutcomesCoronavirus Infection
NCT04376658Hospital Moinhos de Vento1,508